Rosemary Sutton

8.7k total citations
116 papers, 3.4k citations indexed

About

Rosemary Sutton is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Rosemary Sutton has authored 116 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Public Health, Environmental and Occupational Health, 43 papers in Hematology and 33 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Rosemary Sutton's work include Acute Lymphoblastic Leukemia research (67 papers), Childhood Cancer Survivors' Quality of Life (27 papers) and Acute Myeloid Leukemia Research (24 papers). Rosemary Sutton is often cited by papers focused on Acute Lymphoblastic Leukemia research (67 papers), Childhood Cancer Survivors' Quality of Life (27 papers) and Acute Myeloid Leukemia Research (24 papers). Rosemary Sutton collaborates with scholars based in Australia, Germany and Netherlands. Rosemary Sutton's co-authors include Brian A. Baldo, J.K. Pollak, C.W. Wrigley, C. D. Nancarrow, André Schrauder, Jeremy Hancock, Jacques J. M. van Dongen, Glenn M. Marshall, Giovanni Cazzaniga and T Flohr and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Rosemary Sutton

114 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosemary Sutton Australia	32	1.7k	1.2k	853	681	523	116	3.4k
Anthony M. Ford United Kingdom	31	2.3k 1.3×	2.0k 1.6×	1.9k 2.2×	951 1.4×	664 1.3×	84	4.3k
Ursula R. Kees Australia	37	876 0.5×	989 0.8×	2.4k 2.8×	252 0.4×	751 1.4×	138	4.8k
Reinald Repp Germany	27	683 0.4×	620 0.5×	918 1.1×	348 0.5×	187 0.4×	55	2.5k
Ramana Tantravahi United States	36	1.4k 0.8×	2.4k 2.0×	2.5k 2.9×	368 0.5×	664 1.3×	79	5.8k
Pamela J. Sykes Australia	27	583 0.3×	505 0.4×	1.1k 1.3×	199 0.3×	305 0.6×	87	2.9k
Karl‐Anton Kreuzer Germany	28	479 0.3×	891 0.7×	1.1k 1.3×	102 0.1×	695 1.3×	91	2.7k
David J. Curtis Australia	31	353 0.2×	789 0.6×	1.5k 1.7×	99 0.1×	429 0.8×	151	4.1k
Kinuko Mitani Japan	41	630 0.4×	2.9k 2.4×	3.8k 4.4×	150 0.2×	1.1k 2.0×	202	6.3k
H. Bohn Germany	38	717 0.4×	572 0.5×	1.6k 1.9×	757 1.1×	290 0.6×	200	5.3k
Kevin G. Osteen United States	49	1.3k 0.8×	342 0.3×	1.1k 1.3×	417 0.6×	280 0.5×	144	7.8k

Countries citing papers authored by Rosemary Sutton

Since Specialization

Citations

This map shows the geographic impact of Rosemary Sutton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Sutton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Sutton more than expected).

Fields of papers citing papers by Rosemary Sutton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Sutton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Sutton. The network helps show where Rosemary Sutton may publish in the future.

Co-authorship network of co-authors of Rosemary Sutton

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Sutton. A scholar is included among the top collaborators of Rosemary Sutton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Sutton. Rosemary Sutton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boeree, Aurélie, Edwin Sonneveld, Anthony V. Moorman, et al.. (2025). IGH rearrangements in Down syndrome acute lymphoblastic leukemia. SHILAP Revista de lepidopterología. 5. 100223–100223. 1 indexed citations

Lane, J. Athene, Edison Ong, Josephine R. Giles, et al.. (2024). Measurable residual disease detection in acute lymphoblastic leukaemia – comparison between NGS and ASO-qPCR. Pathology. 56. S97–S97. 1 indexed citations

Yeung, David T, Laura N Eadie, Susan L. Heatley, et al.. (2024). Diagnostic genomic analysis is prognostic in AYA patients with ALL treated on an MRD-stratified pediatric protocol. PubMed. 2(1). 100041–100041. 1 indexed citations

Boeree, Aurélie, Edwin Sonneveld, Anthony V. Moorman, et al.. (2023). Targeted treatment options for paediatric B-cell precursor acute lymphoblastic leukaemia patients with constitutional or somatic chromosome 21 alterations. SHILAP Revista de lepidopterología. 3. 100140–100140. 2 indexed citations

Heatley, Susan L., Laura N Eadie, Barbara J. McClure, et al.. (2023). Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients. Cancers. 15(19). 4731–4731. 5 indexed citations

Hughes, Elizabeth, David M. Ross, Matthew Greenwood, et al.. (2022). Sensitive Measurement of Minimal Residual Disease in Blood by HAT-PCR. Journal of Molecular Diagnostics. 24(6). 632–641. 2 indexed citations

Fleming, Shaun, John Reynolds, Ashish Bajel, et al.. (2021). Sequential Blinatumomab with Reduced Intensity Chemotherapy in the Treatment of Older Adults with Newly Diagnosed Ph Negative B-Precursor Acute Lymphoblastic Leukemia - Interim Analysis of the Australasian Leukemia and Lymphoma Group ALL08 Study. Blood. 138(Supplement 1). 1234–1234. 10 indexed citations

Sutton, Rosemary, Luciano Dalla Pozza, Seong Lin Khaw, et al.. (2021). Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab. Pediatric Blood & Cancer. 68(5). e28922–e28922. 17 indexed citations

Brown, Lauren M., Andrew Lonsdale, N. Davidson, et al.. (2020). The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia. Blood Advances. 4(5). 930–942. 53 indexed citations

10.

Langenhorst, Jurgen, Alan V. Boddy, Rosemary Sutton, et al.. (2019). Optimization of a clofarabine‐based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia. Pediatric Blood & Cancer. 67(4). e28133–e28133. 4 indexed citations

11.

Afrin, Sadia, Christine Zhang, Claus Meyer, et al.. (2017). Targeted Next-Generation Sequencing for Detecting MLL Gene Fusions in Leukemia. Molecular Cancer Research. 16(2). 279–285. 29 indexed citations

12.

Richmond, Jennifer, Alissa K. Robbins, Kathryn Evans, et al.. (2016). Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant. Cancer Research. 76(15). 4579–4591. 18 indexed citations

13.

Dolai, Sibasish, Alissa K. Robbins, Ling Zhong, et al.. (2016). Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia. Cancer Research. 76(9). 2766–2777. 12 indexed citations

14.

Richmond, Jennifer, Hernán Carol, Kathryn Evans, et al.. (2015). Effective Targeting of the P53–MDM2 Axis in Preclinical Models of Infant MLL -Rearranged Acute Lymphoblastic Leukemia. Clinical Cancer Research. 21(6). 1395–1405. 41 indexed citations

15.

Moorman, Anthony V., Julie Irving, Amir Enshaei, et al.. (2015). Composite Index for Risk Prediction in Relapsed Childhood Acute Lymphoblastic Leukaemia. Haematologica. 100. 195–196. 3 indexed citations

16.

Szczepański, Tomasz, Vincent H. J. van der Velden, Esmé Waanders, et al.. (2011). Late Recurrence of Childhood T-Cell Acute Lymphoblastic Leukemia Frequently Represents a Second Leukemia Rather Than a Relapse: First Evidence for Genetic Predisposition. Journal of Clinical Oncology. 29(12). 1643–1649. 51 indexed citations

17.

Parker, Catriona, Rachel Waters, Jeremy Hancock, et al.. (2010). Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. The Lancet. 376(9757). 2009–2017. 229 indexed citations

18.

Sutton, Rosemary, et al.. (1995). Growth factor expression in skin during wool follicle development. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 110(4). 697–705. 7 indexed citations

19.

Sutton, Rosemary, et al.. (1991). MYC Protooncogenes of Wool and Hair Growth^a. Annals of the New York Academy of Sciences. 642(1). 326–338. 14 indexed citations

20.

Bruère, A.N., Rosemary Sutton, & G.B. Davis. (1970). Observations on a case of equine lymphosarcoma. New Zealand Veterinary Journal. 18(11). 244–252. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact